CVS Health Rises 3.3%, Elevance Increases 3.2%, Cigna Gains 1.3%, Humana Climbs 2.9%, Molina Healthcare Up 3% in Premarket Trading
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 7 hours ago
0mins
Source: moomoo
CVS Health Growth: CVS Health reported a growth of 3.3% in its recent performance metrics.
Elevance Health Performance: Elevance Health experienced a 3.2% increase in its financial results.
Cigna's Increase: Cigna saw a 1.3% rise in its performance indicators.
Humana and Molina Health Care: Humana's growth was recorded at 2.9%, while Molina Health Care reported a 3% increase.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UNH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UNH
Wall Street analysts forecast UNH stock price to rise
19 Analyst Rating
16 Buy
3 Hold
0 Sell
Strong Buy
Current: 323.480
Low
330.00
Averages
397.82
High
444.00
Current: 323.480
Low
330.00
Averages
397.82
High
444.00
About UNH
UnitedHealth Group Incorporated is a healthcare and well-being company. Its segments include Optum Health, Optum Insight, Optum Rx, and UnitedHealthcare, which includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement and UnitedHealthcare Community & State. Optum Health provides comprehensive and patient-centered care, addressing the physical, mental, and social well-being. Optum Health delivers primary, specialty and surgical care and helps patients and providers navigate and address complex, chronic and behavioral health needs. Optum Insight connects the healthcare system with services, analytics and platforms that make clinical, administrative and financial processes simpler and more efficient for all participants in the healthcare system. Optum Rx offers a range of pharmacy care services through retail pharmacies, through home delivery, specialty and community health pharmacies and the provision of in-home and community-based infusion services.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
UNITEDHEALTH STOCK RISES 5.2% IN PREMARKET TRADING FOLLOWING Q1 PROFIT BEAT
- Market Performance: United Health shares increased by 5.2% in pre-market trading following the release of their Q1 profit report.
- Profit Exceeding Estimates: The company's reported profits were above analysts' expectations, contributing to the positive market reaction.
See More
UnitedHealth Group's Outlook Analysis
- Earnings Forecast Adjustment: Piper Sandler reiterated an 'Overweight' rating and raised its price target to $399, implying a 23% upside from current levels, with expected 2026 EPS at $17.79, aligning with company guidance, reflecting market confidence in UnitedHealth's future profitability.
- Payment Pressure: Despite bullish analyst updates, revisions to Medicare Advantage reimbursements remain a major swing factor for earnings recovery, with an estimated $6 billion impact on revenue through 2026, highlighting the company's vulnerability in the Medicare sector.
- Optum Health's Importance: UnitedHealth's turnaround narrative increasingly hinges on Optum Health's performance, which exited Medicare Advantage plans in 109 counties affecting 180,000 members; however, the company claims to have entered 2026 on a stronger foundation, emphasizing its focus on future profitability.
- Investor Sentiment Shift: Retail sentiment for UnitedHealth surged from neutral to bullish on Stocktwits, with message volumes increasing over 1,150%, indicating heightened market interest in the upcoming earnings report and guidance, potentially driving stock price rebounds in the coming months.
See More
UnitedHealthcare Expands Rural Healthcare Initiatives Nationwide
- Payment Acceleration Program: UnitedHealthcare's Rural Payment Acceleration Pilot, launched in January 2026, reduces Medicare Advantage payment times from 30 days to under 15 days for approximately 1,500 rural hospitals, significantly enhancing cash flow and financial sustainability.
- Authorization Requirement Exemption: By fall 2026, UnitedHealthcare will exempt most medical prior authorization requirements for about 1,500 rural hospitals and their practitioners, alleviating cost and staffing pressures and allowing providers to focus more on patient care.
- Hub-and-Spoke Model: UnitedHealthcare is partnering with leading health systems to implement hub-and-spoke care models that enhance continuity of care in rural areas, focusing initially on maternity care, diabetes, and post-surgical care through advanced mobile and virtual care capabilities.
- Ongoing Investment Commitment: UnitedHealthcare is committed to further investments in rural healthcare, ensuring that these vulnerable providers receive the necessary support to deliver quality care to local residents, thereby enhancing their financial stability.
See More
Challenges Arise in Medicare Obesity Drug Coverage Program
- Uncertainty in Medicare Program: UnitedHealth has indicated that there are 'challenges' surrounding the Medicare pilot program for obesity drug coverage, creating uncertainty about whether health insurers will opt in, which could impact market demand for these drugs.
- Negotiation of Coverage Terms: The program, named Balance, involves the U.S. Centers for Medicare and Medicaid Services negotiating guaranteed net prices directly, potentially capping out-of-pocket costs for GLP-1 drugs from Eli Lilly and Novo Nordisk, yet many unresolved questions remain about the current structure.
- Lack of Participation: While UnitedHealth has committed to participating in the Medicare GLP-1 payment demonstration, CVS Health's Aetna has declined to join the obesity coverage program, reflecting insurers' concerns and uncertainties regarding the model.
- Negative Market Reaction: Concerns over the program have led to a nearly 2% drop in Eli Lilly's shares and a 3.4% decline in Novo Nordisk's stock, indicating investor worries about the potential impact of Medicare reforms on drug sales.
See More
UnitedHealth Group Shares Surge 8% After Strong Q1 Earnings
- Earnings Beat: UnitedHealth Group reported Q1 revenue of $111.7 billion and an adjusted EPS of $7.23, marking a 2% increase from last year's $109.6 billion, exceeding analyst expectations of $109.6 billion and $6.57 EPS, indicating signs of recovery.
- Guidance Upgrade: The company raised its full-year adjusted EPS guidance to over $18.25, significantly above the market estimate of $17.86 and last year's $16.35, reflecting strong future growth potential.
- Cost Management Improvement: The management of medical coverage costs has improved, with the benefits ratio decreasing from 84.8% last year to 83.9% this quarter, well below the analysts' expectation of 85.6%, which will enhance profitability.
- Impact of New CEO: New CEO Stephen Hemsley, who returned to lead the company mid-last year, has helped steer the company out of difficulties; although one solid quarter does not establish a long-term trend, market confidence in future performance is recovering.
See More
UnitedHealth Group Raises 2026 Profit Guidance After Strong Q1 Earnings
- Earnings Beat: UnitedHealth Group reported Q1 revenue of $111.72 billion, a 2% increase year-over-year, surpassing analysts' expectations of $109.57 billion, indicating strong performance in the health insurance market and likely boosting investor confidence.
- Guidance Upgrade: The management raised the 2026 earnings per share forecast from $17.10 to $17.35, with adjusted EPS expectations increasing from $17.75 to $18.25, reflecting a positive outlook on the company's future profitability.
- Market Share Dominance: UnitedHealth Group holds the largest share in the Medicaid market with a market cap of $315 billion, significantly outpacing competitors, and its free cash flow of $16 billion over the past year underscores its financial strength and competitive edge.
- Accelerated Tech Investments: The CEO stated that the company has refocused on U.S. healthcare and is ramping up investments in technology and AI, which are expected to enhance operational efficiency and service quality, thereby improving customer satisfaction and market share.
See More
UNITEDHEALTH STOCK RISES 5.2% IN PREMARKET TRADING FOLLOWING Q1 PROFIT BEAT
- Market Performance: United Health shares increased by 5.2% in pre-market trading following the release of their Q1 profit report.
- Profit Exceeding Estimates: The company's reported profits were above analysts' expectations, contributing to the positive market reaction.
See More
UnitedHealth Group's Outlook Analysis
- Earnings Forecast Adjustment: Piper Sandler reiterated an 'Overweight' rating and raised its price target to $399, implying a 23% upside from current levels, with expected 2026 EPS at $17.79, aligning with company guidance, reflecting market confidence in UnitedHealth's future profitability.
- Payment Pressure: Despite bullish analyst updates, revisions to Medicare Advantage reimbursements remain a major swing factor for earnings recovery, with an estimated $6 billion impact on revenue through 2026, highlighting the company's vulnerability in the Medicare sector.
- Optum Health's Importance: UnitedHealth's turnaround narrative increasingly hinges on Optum Health's performance, which exited Medicare Advantage plans in 109 counties affecting 180,000 members; however, the company claims to have entered 2026 on a stronger foundation, emphasizing its focus on future profitability.
- Investor Sentiment Shift: Retail sentiment for UnitedHealth surged from neutral to bullish on Stocktwits, with message volumes increasing over 1,150%, indicating heightened market interest in the upcoming earnings report and guidance, potentially driving stock price rebounds in the coming months.
See More
UnitedHealthcare Expands Rural Healthcare Initiatives Nationwide
- Payment Acceleration Program: UnitedHealthcare's Rural Payment Acceleration Pilot, launched in January 2026, reduces Medicare Advantage payment times from 30 days to under 15 days for approximately 1,500 rural hospitals, significantly enhancing cash flow and financial sustainability.
- Authorization Requirement Exemption: By fall 2026, UnitedHealthcare will exempt most medical prior authorization requirements for about 1,500 rural hospitals and their practitioners, alleviating cost and staffing pressures and allowing providers to focus more on patient care.
- Hub-and-Spoke Model: UnitedHealthcare is partnering with leading health systems to implement hub-and-spoke care models that enhance continuity of care in rural areas, focusing initially on maternity care, diabetes, and post-surgical care through advanced mobile and virtual care capabilities.
- Ongoing Investment Commitment: UnitedHealthcare is committed to further investments in rural healthcare, ensuring that these vulnerable providers receive the necessary support to deliver quality care to local residents, thereby enhancing their financial stability.
See More
Challenges Arise in Medicare Obesity Drug Coverage Program
- Uncertainty in Medicare Program: UnitedHealth has indicated that there are 'challenges' surrounding the Medicare pilot program for obesity drug coverage, creating uncertainty about whether health insurers will opt in, which could impact market demand for these drugs.
- Negotiation of Coverage Terms: The program, named Balance, involves the U.S. Centers for Medicare and Medicaid Services negotiating guaranteed net prices directly, potentially capping out-of-pocket costs for GLP-1 drugs from Eli Lilly and Novo Nordisk, yet many unresolved questions remain about the current structure.
- Lack of Participation: While UnitedHealth has committed to participating in the Medicare GLP-1 payment demonstration, CVS Health's Aetna has declined to join the obesity coverage program, reflecting insurers' concerns and uncertainties regarding the model.
- Negative Market Reaction: Concerns over the program have led to a nearly 2% drop in Eli Lilly's shares and a 3.4% decline in Novo Nordisk's stock, indicating investor worries about the potential impact of Medicare reforms on drug sales.
See More
UnitedHealth Group Shares Surge 8% After Strong Q1 Earnings
- Earnings Beat: UnitedHealth Group reported Q1 revenue of $111.7 billion and an adjusted EPS of $7.23, marking a 2% increase from last year's $109.6 billion, exceeding analyst expectations of $109.6 billion and $6.57 EPS, indicating signs of recovery.
- Guidance Upgrade: The company raised its full-year adjusted EPS guidance to over $18.25, significantly above the market estimate of $17.86 and last year's $16.35, reflecting strong future growth potential.
- Cost Management Improvement: The management of medical coverage costs has improved, with the benefits ratio decreasing from 84.8% last year to 83.9% this quarter, well below the analysts' expectation of 85.6%, which will enhance profitability.
- Impact of New CEO: New CEO Stephen Hemsley, who returned to lead the company mid-last year, has helped steer the company out of difficulties; although one solid quarter does not establish a long-term trend, market confidence in future performance is recovering.
See More
UnitedHealth Group Raises 2026 Profit Guidance After Strong Q1 Earnings
- Earnings Beat: UnitedHealth Group reported Q1 revenue of $111.72 billion, a 2% increase year-over-year, surpassing analysts' expectations of $109.57 billion, indicating strong performance in the health insurance market and likely boosting investor confidence.
- Guidance Upgrade: The management raised the 2026 earnings per share forecast from $17.10 to $17.35, with adjusted EPS expectations increasing from $17.75 to $18.25, reflecting a positive outlook on the company's future profitability.
- Market Share Dominance: UnitedHealth Group holds the largest share in the Medicaid market with a market cap of $315 billion, significantly outpacing competitors, and its free cash flow of $16 billion over the past year underscores its financial strength and competitive edge.
- Accelerated Tech Investments: The CEO stated that the company has refocused on U.S. healthcare and is ramping up investments in technology and AI, which are expected to enhance operational efficiency and service quality, thereby improving customer satisfaction and market share.
See More
